Alain Klapholz active positions
| Companies | Position | Start | End |
|---|---|---|---|
OptMed, Inc.
 OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | Director of Finance/CFO | 2022-01-13 | - |
| Chief Tech/Sci/R&D Officer | 2006-12-31 | - | |
| Founder | 2006-12-31 | - | |
| Chief Executive Officer | 2006-12-31 | 2012-12-31 |
Career history of Alain Klapholz
Training of Alain Klapholz
| Yeshiva University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Statistics
International
| United States | 4 |
Operational
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director of Finance/CFO | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Alain Klapholz
- Experience
